Insmed Inc (INSM)

16.54
0.15 0.90
NASDAQ : Health Care
Prev Close 16.69
Open 16.67
Day Low/High 16.62 / 16.85
52 Wk Low/High 9.02 / 28.66
Volume 21.73K
Avg Volume 310.20K
Exchange NASDAQ
Shares Outstanding 62.02M
Market Cap 980.59M
EPS -2.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Insmed Inc. Extends ARIKAYCE Intellectual Property Protection With Issuance Of New U.S. Patent

Insmed Inc. Extends ARIKAYCE Intellectual Property Protection With Issuance Of New U.S. Patent

Extends Patent Protection in U.S. by More than Five Years, into 2034

First Week of August 18th Options Trading For Insmed (INSM)

First Week of August 18th Options Trading For Insmed (INSM)

Investors in Insmed Inc saw new options become available this week, for the August 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 205 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week of May 2017 Options Trading For Insmed (INSM)

First Week of May 2017 Options Trading For Insmed (INSM)

Investors in Insmed Inc saw new options begin trading this week, for the May 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 190 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Health Sector Down As Report of Industry Price Collusion Surfaces

Health Sector Down As Report of Industry Price Collusion Surfaces

The healthcare sector was dragged down by reports of price collusion and worse-than-expected third-quarter profits.

Insmed is Now Oversold (INSM)

Insmed is Now Oversold (INSM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insmed Announces Worldwide License Agreement With AstraZeneca For Oral DPP1 Inhibitor

Insmed Announces Worldwide License Agreement With AstraZeneca For Oral DPP1 Inhibitor

Insmed expects to advance compound into a phase 2 dose-ranging study in non-cystic fibrosis bronchiectasis in 2017

Commit To Buy Insmed At $12, Earn 34.2% Using Options

Commit To Buy Insmed At $12, Earn 34.2% Using Options

Investors considering a purchase of Insmed Inc stock, but cautious about paying the going market price of $14.62/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December 2017 put at the $12 strike, which has a bid at the time of this writing of $4.10.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Insmed Incorporated Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 13, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Insmed Incorporated Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 13, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Insmed Incorporated ("Insmed" or the "Company") (NASDAQ: INSM )...

INSM SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Insmed Incorporated And A Lead Plaintiff Deadline Of September 13, 2016

INSM SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Insmed Incorporated And A Lead Plaintiff Deadline Of September 13, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Insmed Incorporated (NASDAQ: INSM) securities between...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Insmed Incorporated Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 13, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Insmed Incorporated Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 13, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Insmed Incorporated ("Insmed" or the "Company") (NASDAQ: INSM )...

Brower Piven Alerts Shareholders Of Upcoming Deadline In Class Action Lawsuit And Encourages Those With Substantial Losses From Investment In Insmed Incorporated To Contact The Firm

Brower Piven Alerts Shareholders Of Upcoming Deadline In Class Action Lawsuit And Encourages Those With Substantial Losses From Investment In Insmed Incorporated To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

INSM SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Insmed Incorporated And A Lead Plaintiff Deadline Of September 13, 2016

INSM SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Insmed Incorporated And A Lead Plaintiff Deadline Of September 13, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Insmed Incorporated (NASDAQ: INSM) securities between...

Insmed Reports Second Quarter 2016 Financial Results

Insmed Reports Second Quarter 2016 Financial Results

Full enrollment in phase 3 CONVERT study remains on track for 2016

STOCK ALERT: Rosen Law Firm Reminds Insmed Incorporated Investors Of Important Deadline In Class Action - INSM

STOCK ALERT: Rosen Law Firm Reminds Insmed Incorporated Investors Of Important Deadline In Class Action - INSM

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Insmed Incorporated securities (NASDAQ:INSM) from March 18, 2013 through June 8, 2016, both dates inclusive (the "Class Period") of the important...